Showing results (231-240 of 364) with videos related to

Sort By:
Pageof 37
Urologic Oncology|March 7, 2020
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapyFernando Caumont, Galen Conti, Lauren M Hurwitz, et al.
Cancer|April 8, 2015
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomyClaudio Jeldres, Jennifer Cullen, Lauren M Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guidelineJennifer J Griggs, Pamela B Mangu, Holly Anderson, et al.
Leukemia Research|September 29, 2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemiaJonathan A Webster, Raoul Tibes, Larry Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeChanning J Paller, Penelope A Bradbury, S Percy Ivy, et al.
Radiology|April 13, 2021
Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy SpecimensStephanie A Harmon, William Gesztes, Denise Young, et al.
Urology|January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate ScoreTimothy C Brand, Nan Zhang, Michael R Crager, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomasD E Thrall, D M Prescott, T V Samulski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2006
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinomaMark J Ratain, Tim Eisen, Walter M Stadler, et al.
Blood Advances|December 16, 2017
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamideYvette L Kasamon, Richard F Ambinder, Ephraim J Fuchs, et al.
Pageof 37